Mometasone Furoate
NDC Package 42291-575-12

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Mometasone Furoate is a medication used to treat skin conditions such as eczema, psoriasis, allergies, and rash. Marketed by Avkare, Inc., this product is identified by NDC 42291-575 and is authorized under FDA application ANDA207989.

Identification & Billing

NDC Package Code
42291-575-12
Package Description
1 BOTTLE, PUMP in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE, PUMP
Product Code
42291-575
11-Digit Billing Format
42291057512
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.

Clinical Specifications

Proprietary Name
Mometasone Furoate
Dosage Form
-
Usage Information
This medication is used to treat skin conditions such as eczema, psoriasis, allergies, and rash. Mometasone decreases swelling (inflammation), itching, and redness. Mometasone is a medium-strength corticosteroid. This medication is available in several forms including cream, ointment, and lotion (solution). Your doctor will choose the type of product based on the skin condition/area of the body being treated.

Regulatory & Marketing

Labeler Name
Avkare, Inc.
FDA Application #
ANDA207989
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-08-2017
End Marketing Date
01-18-2018
Listing Expiration
01-18-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42291-575-12 identifies a specific commercial package of 1 bottle, pump in 1 carton / 120 spray, metered in 1 bottle, pump of Mometasone Furoate, labeled by Avkare, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Avkare, Inc. on June 08, 2017. The current certification is valid through January 18, 2018.

What are the primary indications for this medication?

This medication is used to treat skin conditions such as eczema, psoriasis, allergies, and rash. Mometasone decreases swelling (inflammation), itching, and redness. Mometasone is a medium-strength corticosteroid. This medication is available in several forms including cream, ointment, and lotion (solution). Your doctor will choose the type of product based on the skin condition/area of the body being treated.

How is this Avkare, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42291057512. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42291-575-12
11-Digit CMS (5-4-2)
42291-0575-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.